There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy ...

"Inhaled insulin comes as a powder and has a component that helps ... People with asthma or chronic obstructive pulmonary disease (COPD) should avoid inhaled insulin. It can raise your chances ...

GSK, leading the COPD market with its Trelegy Ellipta inhaler ... choosing the best therapy for each patient. "Are dry powder inhalers the key to sustainable respiratory care?" ...

Inhaled corticosteroids are often used outside of the recommended indications in COPD. Researchers revealed a link between long-term use and several risks for new diagnoses. Adults with COPD who ...

chronic obstructive pulmonary disease (COPD), and certain other respiratory conditions typically receive Medicare coverage for inhalers. To receive coverage, a person must have a Medicare ...

Treat immediately with an inhaled short-acting beta1-agonist ... After chronic once-daily dry powder inhalation by COPD patients, pharmacokinetic steady state was reached by day 7 with no ...

The Spiriva Respimat inhaler is a cylindrical shaped plastic ... After chronic once-daily dry powder inhalation by COPD patients, pharmacokinetic steady state was reached by day 7 with no ...

BRETARIS GENUAIR is a dry powder inhaler that uses your breath to deliver the medicine directly into your lungs. This makes it easier for chronic obstructive pulmonary disease (COPD) patients to ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

The deal to develop a sensor for Novartis' dry powder inhaler Breezhaler adds to the ... with technology companies seeking to digitise COPD management. Early last year, the Swiss pharma sealed ...

Innovata Biomed Ltd has developed an alternative device, the Clickhaler®, which is a multiple-dose dry powder inhaler (DPI). The present study compared patient acceptability of the salbutamol ...

Aim: (1) To compare the efficacy and adverse effects of treatment using nebulizers vs pressurized metered-dose inhalers (MDIs) with or without a spacer/holding chamber vs dry powder inhalers (DPIs ...